Product: Rifadin (rifampin) capsules, USP, 150 mg, 100-count capsules per bottle, Manufactured by: Fabrique par Sanofi-Aventis Canada Inc., Laval, Quebec, Canada H7L4A8, DIN # 02091887
Reason for recall: Subpotent Drug:  During review of retain samples, the manufacturer observed low fill in some capsules, which was related to an issue detected with the encapsulating equipment.
Recall initiated: 20130226
Status: Terminated
Classification: Class II
Recall type: Voluntary: Firm initiated